Bioxcel Therapeutics Stock Market Value
| BTAI Stock | USD 2.71 0.26 8.75% |
| Symbol | BioXcel |
BioXcel Therapeutics Price To Book Ratio
Is BioXcel Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioXcel Therapeutics. If investors know BioXcel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioXcel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.15) | Revenue Per Share 0.047 | Quarterly Revenue Growth 0.58 | Return On Assets (0.75) | Return On Equity (17.67) |
The market value of BioXcel Therapeutics is measured differently than its book value, which is the value of BioXcel that is recorded on the company's balance sheet. Investors also form their own opinion of BioXcel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is BioXcel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioXcel Therapeutics' market value can be influenced by many factors that don't directly affect BioXcel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioXcel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioXcel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioXcel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioXcel Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioXcel Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioXcel Therapeutics.
| 03/26/2024 |
| 04/25/2024 |
If you would invest 0.00 in BioXcel Therapeutics on March 26, 2024 and sell it all today you would earn a total of 0.00 from holding BioXcel Therapeutics or generate 0.0% return on investment in BioXcel Therapeutics over 30 days. BioXcel Therapeutics is related to or competes with Terns Pharmaceuticals, Amylyx Pharmaceuticals, Acumen Pharmaceuticals, Inozyme PharmaInc, X4 Pharmaceuticals, Day One, and Apellis Pharmaceuticals. BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches ... More
BioXcel Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioXcel Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioXcel Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.15 | |||
| Information Ratio | 0.0626 | |||
| Maximum Drawdown | 64.98 | |||
| Value At Risk | (7.05) | |||
| Potential Upside | 17.08 |
BioXcel Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioXcel Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioXcel Therapeutics' standard deviation. In reality, there are many statistical measures that can use BioXcel Therapeutics historical prices to predict the future BioXcel Therapeutics' volatility.| Risk Adjusted Performance | 0.055 | |||
| Jensen Alpha | 0.5956 | |||
| Total Risk Alpha | (0.57) | |||
| Sortino Ratio | 0.0608 | |||
| Treynor Ratio | 1.2 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioXcel Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BioXcel Therapeutics Backtested Returns
We consider BioXcel Therapeutics risky. BioXcel Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0134, which signifies that the company had a 0.0134% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for BioXcel Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm BioXcel Therapeutics' Mean Deviation of 5.03, downside deviation of 9.15, and Risk Adjusted Performance of 0.055 to double-check if the risk estimate we provide is consistent with the expected return of 0.12%. BioXcel Therapeutics has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.54, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BioXcel Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding BioXcel Therapeutics is expected to be smaller as well. BioXcel Therapeutics right now shows a risk of 8.97%. Please confirm BioXcel Therapeutics total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to decide if BioXcel Therapeutics will be following its price patterns.
Auto-correlation | -0.07 |
Very weak reverse predictability
BioXcel Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between BioXcel Therapeutics time series from 26th of March 2024 to 10th of April 2024 and 10th of April 2024 to 25th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioXcel Therapeutics price movement. The serial correlation of -0.07 indicates that barely 7.0% of current BioXcel Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
BioXcel Therapeutics lagged returns against current returns
Autocorrelation, which is BioXcel Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioXcel Therapeutics' stock expected returns. We can calculate the autocorrelation of BioXcel Therapeutics returns to help us make a trade decision. For example, suppose you find that BioXcel Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioXcel Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioXcel Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioXcel Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioXcel Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
BioXcel Therapeutics Lagged Returns
When evaluating BioXcel Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioXcel Therapeutics stock have on its future price. BioXcel Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioXcel Therapeutics autocorrelation shows the relationship between BioXcel Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in BioXcel Therapeutics.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioXcel Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioXcel Therapeutics' short interest history, or implied volatility extrapolated from BioXcel Therapeutics options trading.
Pair Trading with BioXcel Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioXcel Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioXcel Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to BioXcel Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioXcel Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioXcel Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioXcel Therapeutics to buy it.
The correlation of BioXcel Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioXcel Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioXcel Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioXcel Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out BioXcel Therapeutics Correlation, BioXcel Therapeutics Volatility and BioXcel Therapeutics Alpha and Beta module to complement your research on BioXcel Therapeutics. For more detail on how to invest in BioXcel Stock please use our How to Invest in BioXcel Therapeutics guide.Note that the BioXcel Therapeutics information on this page should be used as a complementary analysis to other BioXcel Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for BioXcel Stock analysis
When running BioXcel Therapeutics' price analysis, check to measure BioXcel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioXcel Therapeutics is operating at the current time. Most of BioXcel Therapeutics' value examination focuses on studying past and present price action to predict the probability of BioXcel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioXcel Therapeutics' price. Additionally, you may evaluate how the addition of BioXcel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
BioXcel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.